Coronavirus
Johnson & Johnson Will Seek Authorization for a Booster Shot This Week
Johnson & Johnson will reportedly seek authorization for a booster shot this week, as concerns are rising regarding the effectiveness of its single-shot COVID-19 vaccine compared to other jabs.
The New York Times, citing unidentified officials familiar with the company’s plans, reported on Monday that Johnson & Johnson is planning to request authorization from the Food and Drug Administration (FDA) early this week for a booster shot, joining Pfizer-BioNTech and Moderna in asking for approval for an additional shot.
The FDA announced on Friday that its expert advisory committee will discuss booster shots for Johnson & Johnson’s vaccine during its meetings on Oct. 14 and 15.
